Welcome to the Minimal Residual Disease (MRD) Educational Multimedia Guide—a comprehensive resource for understanding minimal residual disease (also known as measurable residual disease or MRD) in multiple myeloma care. MRD testing offers deep insights into how well your treatment is working and what it means for your future care.

This guide is most useful for patients and caregivers who are familiar with myeloma treatment response terminology (overall response, progression-free survival, complete response, etc.). If this is the first time that you are exploring responses to myeloma treatment, we suggest that you start your learning here: Myeloma Clinical Trial Guide: What Endpoints Mean for You.

Another helpful resource if you are starting your myeloma education is our 101 pages. 

To navigate the guide, use the PREVIOUS and NEXT buttons at the bottom of the page or explore the menu to go directly to a specific section. Don't miss the 'Continue Your Learning' pages at the end of each section, where you will find infographics, downloadable resources, further reading, and recordings of expert webinars.

This guide was created independently by HealthTree, along with myeloma patients and caregivers.

Thanks to our sponsor: 

Authors: Audrey Burton-Bethke, Marta Llobet Canela

Pending Medical Review